I nostri Partner | IGEA Medical
TAKIS S.r.l. – Tecnopolo
Takis | LinkedIn
Home
News
Takis Biotech
Settore biotecnologico: dal vaccino contro il cancro al COVID-19
Applied DNA and Takis Biotech partner on coronavirus vaccine
Applied DNA Sciences and Takis Biotech
Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNAT Vaccine Candidates Designed
Home
Applied DNA, Takis Biotech partner on coronavirus vaccine - Applied DNA Sciences
Takis – società biotech in campo contro il coronavirus – Tecnopolo
Takis Biotech Interview - Italy Life Sciences 2021
COVID-eVax, il vaccino made in Italy efficace contro virus e varianti
Coronavirus, vaccino made in Italy: al via i test nell'azienda romana Takis
Rottapharm Biotech and Takis enter an agreement for the co-development of the vaccine against COVID-19 - Rottapharm Biotech
Together for Healthier Lives in Europe
Takis Biotech Interview - Italy Life Sciences 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models: Molecular Therapy
Vaccino italiano Takis e Rottapharm pronto per i test - la Repubblica
